Predictive Efficacy Biomarkers of Programmed Cell Death 1/Programmed Cell Death 1 Ligand Blockade Therapy
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
11
Page:
141-151
Author(s):
Xiao-Na Fang and Li-Wu Fu
Oncotarget Strategies For Herpes Simplex Virus-1
Journal:
Current Gene Therapy
Volume:
16
Page:
130-143
Author(s):
Lumin Zhang, Tsurumi Tatsuya and Yukihiro Nishiyama
Tannic Acid Inhibits Proliferation, Migration, Invasion of Prostate Cancer and Modulates Drug Metabolizing and Antioxidant Enzymes
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
16
Page:
781-789
Author(s):
Serdar Karakurt and Orhan Adali
Targeting the Cancer Biomarker CD47: A Review on the Diverse Mechanisms of the CD47 Pathway in Cancer Treatment
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
16
Page:
658-667
Author(s):
Liang Zhang and He Huang
Metal Containing Cytostatics and Their Interaction with Cellular Thiol Compounds Causing Chemoresistance
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
16
Page:
686-698
Author(s):
Jan Hrabeta, Vojtech Adam, Tomas Eckschlager, Eva Frei, Marie Stiborova and Rene Kizek
Emerging Immunotargets in Bladder Cancer
Journal:
Current Drug Targets
Volume:
17
Page:
757-770
Author(s):
Francesco Massari, Chiara Ciccarese, Nuno Vau, Matteo Santoni, Rodolfo Montironi, Liang Cheng, Rita C. Marques, Marina Scarpelli, Jorge Fonseca, Marc R Matrana, Moch Holger, Stefano Cascinu, Giampaolo Tortora and Antonio Lopez-Beltran
An Overview of Emerging Immunotargets of Genitourinary Tumors
Journal:
Current Drug Targets
Volume:
17
Page:
750-756
Author(s):
Rodolfo Montironi, Matteo Santoni, Liang Cheng, Antonio Lopez-Beltran, Francesco Massari, Marc R. Matrana, Holger Moch and Marina Scarpelli
Editorial (Thematic Issue: Emerging Immunotargets in Genitourinary Tumors)
Journal:
Current Drug Targets
Volume:
17
Page:
748-749
Author(s):
Rodolfo Montironi, Matteo Santoni, Francesco Massari, Antonio Lopez-Beltran, Liang Cheng, Rossana Berardi and Marina Scarpelli
HOX Genes as Potential Markers of Circulating Tumour Cells
Journal:
Current Molecular Medicine
Volume:
16
Page:
322-327
Author(s):
R. Morgan and M. El-Tanani
Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin
Journal:
Current Cancer Drug Targets
Volume:
16
Page:
288-304
Author(s):
Zhipeng Zou, Juan Chen, Jun Yang and Xiaochun Bai